Magle Chemoswed Q2 2023: Progress toward transition
Research Update
2023-07-19
07:30
Redeye provides a research update following the Q2 report published by Magle yesterday. Overall, the report was in line with our expectations. However, we are encouraged by the progress made by the company during the period. We reiterate our previous fair value range (SEK25 – SEK58) with a base case valuation of SEK40 as we continue to have a positive outlook on the case.
KS
Kevin Sule
Disclosures and disclaimers